cereneo Revenue and Competitors
Employee Data
- cereneo has 73 Employees.
- cereneo grew their employee count by 20% last year.
cereneo's People
Name | Title | Email/Phone |
---|
cereneo Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | N/A | 373 | 12% | N/A | N/A |
#2 | N/A | 55 | 0% | N/A | N/A |
#3 | N/A | 121 | 6% | N/A | N/A |
#4 | N/A | 152 | -13% | N/A | N/A |
#5 | N/A | 117 | -2% | N/A | N/A |
#6 | N/A | 104 | 11% | N/A | N/A |
#7 | N/A | 176 | 31% | N/A | N/A |
#8 | N/A | 81 | 88% | N/A | N/A |
#9 | N/A | 78 | 10% | N/A | N/A |
#10 | N/A | 73 | 20% | N/A | N/A |
What Is cereneo?
cereneo is a clinic and research facility specialised in neurorehabilitation originated and based in Switzerland. Located at the banks of Lake Lucerne in the breathtaking scenery of the Swiss Alps, we offer state-of-the-art neurorehabilitation at our facilities cereneo Vitznau and cereneo Hertenstein, as well as individualised home treatment carried out in collaboration with our partners. Currently we are employing around 80 professionals from different areas involved in the recovery process such as care specialists, therapists, neuro-psychologists, neurologists and nutrition experts. These experts work closely together in an interdisciplinary team. Following a very personal and intense approach our team applies the latest therapy methods as well as state-of-the-art robotic systems aiming to give our patients back the highest possible level of independence and to enhance their quality of life. Are you a highly motivated individual who is passionate about neurorehabilitation, interested in new technology and enjoys working in a team? We’d love to hear from you! For more information, please visit our website: www.cereneo.ch
keywords:N/AN/A
Total Funding
73
Number of Employees
N/A
Revenue (est)
20%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $32.4M | 120 | 8% | N/A |
#2 | $154M | 349 | 5% | N/A |